Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Baicalin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Apabetalone
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/18/2021
Sargassum horneri polysaccharide extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/15/2021
L-Carnitine
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/14/2021
PCI-27483
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Antipain
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Soybean Trypsin Inhibitor
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Avoralstat
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Enoxaparin
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/12/2021
Naproxol
Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021
(E)-4-(4-((5-(4,5-Dimethyl-2-nitrophenyl)furan-2-yl)Methylene)-3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid
Potential treatment - theoretical effect Experimental Other treatment Apr/12/2021
Amsacrine
Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021
Teniposide
Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021
Palbociclib
Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021
Trichostatin A
Potential treatment - theoretical effect Natural product Antiviral Apr/10/2021
(-)-Gallocatechin gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/09/2021
Quinine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/09/2021
Epigallocatechin Gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021
NVX-CoV2373
Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021
Niclosamide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/07/2021